IndicatorCode,Indicator,ValueType,ParentLocationCode,ParentLocation,Location type,SpatialDimValueCode,Location,Period type,Period,IsLatestYear,Dim1 type,Dim1,Dim1ValueCode,Dim2 type,Dim2,Dim2ValueCode,Dim3 type,Dim3,Dim3ValueCode,DataSourceDimValueCode,DataSource,FactValueNumericPrefix,FactValueNumeric,FactValueUoM,FactValueNumericLowPrefix,FactValueNumericLow,FactValueNumericHighPrefix,FactValueNumericHigh,Value,FactValueTranslationID,FactComments,Language,DateModified
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,SAU,Saudi Arabia,Year,2020,true,,,,,,,,,,,,,0,,,0,,0,0 [0 – 0],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,ARG,Argentina,Year,2020,true,,,,,,,,,,,,,0.01,,,0.01,,0.02,0.01 [0.01 – 0.02],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,POL,Poland,Year,2020,true,,,,,,,,,,,,,0.01,,,0.01,,0.02,0.01 [0.01 – 0.02],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,USA,United States of America,Year,2020,true,,,,,,,,,,,,,0.01,,,0.01,,0.02,0.01 [0.01 – 0.02],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,CRI,Costa Rica,Year,2020,true,,,,,,,,,,,,,0.02,,,0.01,,0.03,0.02 [0.01 – 0.03],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,NOR,Norway,Year,2020,true,,,,,,,,,,,,,0.02,,,0.01,,0.03,0.02 [0.01 – 0.03],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,ARE,United Arab Emirates,Year,2020,true,,,,,,,,,,,,,0.02,,,0.01,,0.03,0.02 [0.01 – 0.03],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,AND,Andorra,Year,2020,true,,,,,,,,,,,,,0.02,,,0.01,,0.04,0.02 [0.01 – 0.04],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,SLV,El Salvador,Year,2020,true,,,,,,,,,,,,,0.02,,,0.01,,0.07,0.02 [0.01 – 0.07],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,PRT,Portugal,Year,2020,true,,,,,,,,,,,,,0.02,,,0.02,,0.03,0.02 [0.02 – 0.03],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,KWT,Kuwait,Year,2020,true,,,,,,,,,,,,,0.03,,,0,,0.19,0.03 [0 – 0.19],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,CUB,Cuba,Year,2020,true,,,,,,,,,,,,,0.03,,,0.01,,0.05,0.03 [0.01 – 0.05],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,PLW,Palau,Year,2020,true,,,,,,,,,,,,,0.03,,,0.01,,0.1,0.03 [0.01 – 0.1],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,HND,Honduras,Year,2020,true,,,,,,,,,,,,,0.03,,,0.01,,0.11,0.03 [0.01 – 0.11],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,BHR,Bahrain,Year,2020,true,,,,,,,,,,,,,0.03,,,0.02,,0.03,0.03 [0.02 – 0.03],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,BRA,Brazil,Year,2020,true,,,,,,,,,,,,,0.03,,,0.02,,0.03,0.03 [0.02 – 0.03],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,GTM,Guatemala,Year,2020,true,,,,,,,,,,,,,0.03,,,0.02,,0.04,0.03 [0.02 – 0.04],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,MEX,Mexico,Year,2020,true,,,,,,,,,,,,,0.03,,,0.02,,0.04,0.03 [0.02 – 0.04],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,CHL,Chile,Year,2020,true,,,,,,,,,,,,,0.03,,,0.02,,0.05,0.03 [0.02 – 0.05],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,IRL,Ireland,Year,2020,true,,,,,,,,,,,,,0.04,,,0.03,,0.05,0.04 [0.03 – 0.05],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,SRB,Serbia,Year,2020,true,,,,,,,,,,,,,0.04,,,0.03,,0.05,0.04 [0.03 – 0.05],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,LTU,Lithuania,Year,2020,true,,,,,,,,,,,,,0.05,,,0.03,,0.07,0.05 [0.03 – 0.07],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,QAT,Qatar,Year,2020,true,,,,,,,,,,,,,0.05,,,0.03,,0.08,0.05 [0.03 – 0.08],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,IRN,Iran (Islamic Republic of),Year,2020,true,,,,,,,,,,,,,0.05,,,0.04,,0.06,0.05 [0.04 – 0.06],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,ISR,Israel,Year,2020,true,,,,,,,,,,,,,0.05,,,0.04,,0.06,0.05 [0.04 – 0.06],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,LUX,Luxembourg,Year,2020,true,,,,,,,,,,,,,0.06,,,0.01,,0.4,0.06 [0.01 – 0.4],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,KNA,Saint Kitts and Nevis,Year,2020,true,,,,,,,,,,,,,0.06,,,0.02,,0.22,0.06 [0.02 – 0.22],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,ARM,Armenia,Year,2020,true,,,,,,,,,,,,,0.06,,,0.03,,0.13,0.06 [0.03 – 0.13],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,GEO,Georgia,Year,2020,true,,,,,,,,,,,,,0.06,,,0.04,,0.08,0.06 [0.04 – 0.08],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,AZE,Azerbaijan,Year,2020,true,,,,,,,,,,,,,0.06,,,0.04,,0.1,0.06 [0.04 – 0.1],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,PER,Peru,Year,2020,true,,,,,,,,,,,,,0.06,,,0.05,,0.07,0.06 [0.05 – 0.07],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,MYS,Malaysia,Year,2020,true,,,,,,,,,,,,,0.06,,,0.05,,0.08,0.06 [0.05 – 0.08],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,TKM,Turkmenistan,Year,2020,true,,,,,,,,,,,,,0.07,,,0.01,,0.43,0.07 [0.01 – 0.43],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,SUR,Suriname,Year,2020,true,,,,,,,,,,,,,0.07,,,0.02,,0.28,0.07 [0.02 – 0.28],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,PAN,Panama,Year,2020,true,,,,,,,,,,,,,0.07,,,0.05,,0.09,0.07 [0.05 – 0.09],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,LBN,Lebanon,Year,2020,true,,,,,,,,,,,,,0.07,,,0.06,,0.09,0.07 [0.06 – 0.09],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,MKD,The former Yugoslav Republic of Macedonia,Year,2020,true,,,,,,,,,,,,,0.08,,,0.03,,0.25,0.08 [0.03 – 0.25],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,DZA,Algeria,Year,2020,true,,,,,,,,,,,,,0.08,,,0.06,,0.1,0.08 [0.06 – 0.1],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,NLD,Netherlands,Year,2020,true,,,,,,,,,,,,,0.08,,,0.07,,0.09,0.08 [0.07 – 0.09],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,SYC,Seychelles,Year,2020,true,,,,,,,,,,,,,0.09,,,0.03,,0.23,0.09 [0.03 – 0.23],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,ECU,Ecuador,Year,2020,true,,,,,,,,,,,,,0.09,,,0.03,,0.33,0.09 [0.03 – 0.33],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,NIC,Nicaragua,Year,2020,true,,,,,,,,,,,,,0.09,,,0.05,,0.17,0.09 [0.05 – 0.17],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,BEL,Belgium,Year,2020,true,,,,,,,,,,,,,0.09,,,0.06,,0.13,0.09 [0.06 – 0.13],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,BGR,Bulgaria,Year,2020,true,,,,,,,,,,,,,0.09,,,0.07,,0.12,0.09 [0.07 – 0.12],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,KOR,Republic of Korea,Year,2020,true,,,,,,,,,,,,,0.09,,,0.08,,0.12,0.09 [0.08 – 0.12],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,DOM,Dominican Republic,Year,2020,true,,,,,,,,,,,,,0.1,,,0.03,,0.37,0.1 [0.03 – 0.37],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,BRN,Brunei Darussalam,Year,2020,true,,,,,,,,,,,,,0.1,,,0.07,,0.14,0.1 [0.07 – 0.14],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,COK,Cook Islands,Year,2020,true,,,,,,,,,,,,,0.1,,,0.07,,0.15,0.1 [0.07 – 0.15],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,TUR,Türkiye,Year,2020,true,,,,,,,,,,,,,0.11,,,0.09,,0.13,0.11 [0.09 – 0.13],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,GRD,Grenada,Year,2020,true,,,,,,,,,,,,,0.12,,,0.04,,0.42,0.12 [0.04 – 0.42],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,HRV,Croatia,Year,2020,true,,,,,,,,,,,,,0.12,,,0.1,,0.16,0.12 [0.1 – 0.16],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,TUN,Tunisia,Year,2020,true,,,,,,,,,,,,,0.12,,,0.1,,0.16,0.12 [0.1 – 0.16],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,SMR,San Marino,Year,2020,true,,,,,,,,,,,,,0.13,,,0.05,,0.34,0.13 [0.05 – 0.34],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,CZE,Czechia,Year,2020,true,,,,,,,,,,,,,0.13,,,0.09,,0.17,0.13 [0.09 – 0.17],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,OMN,Oman,Year,2020,true,,,,,,,,,,,,,0.13,,,0.09,,0.18,0.13 [0.09 – 0.18],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,SWE,Sweden,Year,2020,true,,,,,,,,,,,,,0.13,,,0.1,,0.17,0.13 [0.1 – 0.17],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,ESP,Spain,Year,2020,true,,,,,,,,,,,,,0.13,,,0.11,,0.15,0.13 [0.11 – 0.15],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,AUS,Australia,Year,2020,true,,,,,,,,,,,,,0.13,,,0.11,,0.16,0.13 [0.11 – 0.16],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,SGP,Singapore,Year,2020,true,,,,,,,,,,,,,0.13,,,0.11,,0.16,0.13 [0.11 – 0.16],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,FJI,Fiji,Year,2020,true,,,,,,,,,,,,,0.13,,,0.11,,0.18,0.13 [0.11 – 0.18],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,BOL,Bolivia (Plurinational State of),Year,2020,true,,,,,,,,,,,,,0.14,,,0.05,,0.29,0.14 [0.05 – 0.29],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,BTN,Bhutan,Year,2020,true,,,,,,,,,,,,,0.14,,,0.11,,0.18,0.14 [0.11 – 0.18],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,GRC,Greece,Year,2020,true,,,,,,,,,,,,,0.14,,,0.12,,0.16,0.14 [0.12 – 0.16],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,URY,Uruguay,Year,2020,true,,,,,,,,,,,,,0.15,,,0.02,,1.21,0.15 [0.02 – 1.21],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,MCO,Monaco,Year,2020,true,,,,,,,,,,,,,0.15,,,0.04,,0.55,0.15 [0.04 – 0.55],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,KGZ,Kyrgyzstan,Year,2020,true,,,,,,,,,,,,,0.15,,,0.04,,0.72,0.15 [0.04 – 0.72],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,ISL,Iceland,Year,2020,true,,,,,,,,,,,,,0.15,,,0.05,,0.4,0.15 [0.05 – 0.4],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,VCT,Saint Vincent and the Grenadines,Year,2020,true,,,,,,,,,,,,,0.15,,,0.05,,0.49,0.15 [0.05 – 0.49],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,KAZ,Kazakhstan,Year,2020,true,,,,,,,,,,,,,0.15,,,0.09,,0.22,0.15 [0.09 – 0.22],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,VEN,Venezuela (Bolivarian Republic of),Year,2020,true,,,,,,,,,,,,,0.15,,,0.12,,0.18,0.15 [0.12 – 0.18],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,COL,Colombia,Year,2020,true,,,,,,,,,,,,,0.15,,,0.12,,0.19,0.15 [0.12 – 0.19],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,FRA,France,Year,2020,true,,,,,,,,,,,,,0.15,,,0.13,,0.18,0.15 [0.13 – 0.18],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,BHS,Bahamas,Year,2020,true,,,,,,,,,,,,,0.16,,,0.01,,4.56,0.16 [0.01 – 4.56],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,AUT,Austria,Year,2020,true,,,,,,,,,,,,,0.16,,,0.1,,0.23,0.16 [0.1 – 0.23],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,CHE,Switzerland,Year,2020,true,,,,,,,,,,,,,0.16,,,0.1,,0.23,0.16 [0.1 – 0.23],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,MAR,Morocco,Year,2020,true,,,,,,,,,,,,,0.16,,,0.13,,0.19,0.16 [0.13 – 0.19],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,NPL,Nepal,Year,2020,true,,,,,,,,,,,,,0.16,,,0.13,,0.2,0.16 [0.13 – 0.2],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,UZB,Uzbekistan,Year,2020,true,,,,,,,,,,,,,0.16,,,0.13,,0.2,0.16 [0.13 – 0.2],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,IND,India,Year,2020,true,,,,,,,,,,,,,0.16,,,0.14,,0.19,0.16 [0.14 – 0.19],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,BRB,Barbados,Year,2020,true,,,,,,,,,,,,,0.18,,,0.05,,0.55,0.18 [0.05 – 0.55],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,BWA,Botswana,Year,2020,true,,,,,,,,,,,,,0.18,,,0.08,,0.38,0.18 [0.08 – 0.38],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,TJK,Tajikistan,Year,2020,true,,,,,,,,,,,,,0.18,,,0.12,,0.25,0.18 [0.12 – 0.25],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,TTO,Trinidad and Tobago,Year,2020,true,,,,,,,,,,,,,0.19,,,0.04,,0.81,0.19 [0.04 – 0.81],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,ATG,Antigua and Barbuda,Year,2020,true,,,,,,,,,,,,,0.19,,,0.07,,0.68,0.19 [0.07 – 0.68],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,KHM,Cambodia,Year,2020,true,,,,,,,,,,,,,0.19,,,0.15,,0.24,0.19 [0.15 – 0.24],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,PRK,Democratic People's Republic of Korea,Year,2020,true,,,,,,,,,,,,,0.2,,,0.01,,3.49,0.2 [0.01 – 3.49],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,MLT,Malta,Year,2020,true,,,,,,,,,,,,,0.2,,,0.05,,0.93,0.2 [0.05 – 0.93],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,DMA,Dominica,Year,2020,true,,,,,,,,,,,,,0.2,,,0.06,,0.6,0.2 [0.06 – 0.6],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,MDA,Republic of Moldova,Year,2020,true,,,,,,,,,,,,,0.2,,,0.16,,0.26,0.2 [0.16 – 0.26],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,EGY,Egypt,Year,2020,true,,,,,,,,,,,,,0.2,,,0.17,,0.24,0.2 [0.17 – 0.24],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,MDV,Maldives,Year,2020,true,,,,,,,,,,,,,0.21,,,0.02,,1.98,0.21 [0.02 – 1.98],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,DEU,Germany,Year,2020,true,,,,,,,,,,,,,0.21,,,0.17,,0.24,0.21 [0.17 – 0.24],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,LCA,Saint Lucia,Year,2020,true,,,,,,,,,,,,,0.22,,,0.06,,0.77,0.22 [0.06 – 0.77],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,CHN,China,Year,2020,true,,,,,,,,,,,,,0.22,,,0.18,,0.28,0.22 [0.18 – 0.28],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,TUV,Tuvalu,Year,2020,true,,,,,,,,,,,,,0.24,,,0.17,,0.33,0.24 [0.17 – 0.33],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,UKR,Ukraine,Year,2020,true,,,,,,,,,,,,,0.25,,,0.18,,0.34,0.25 [0.18 – 0.34],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,DJI,Djibouti,Year,2020,true,,,,,,,,,,,,,0.26,,,0.04,,1.53,0.26 [0.04 – 1.53],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,CPV,Cabo Verde,Year,2020,true,,,,,,,,,,,,,0.26,,,0.17,,0.37,0.26 [0.17 – 0.37],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,LVA,Latvia,Year,2020,true,,,,,,,,,,,,,0.27,,,0.12,,0.56,0.27 [0.12 – 0.56],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,THA,Thailand,Year,2020,true,,,,,,,,,,,,,0.27,,,0.23,,0.32,0.27 [0.23 – 0.32],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,IRQ,Iraq,Year,2020,true,,,,,,,,,,,,,0.29,,,0.14,,0.54,0.29 [0.14 – 0.54],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,EST,Estonia,Year,2020,true,,,,,,,,,,,,,0.29,,,0.16,,0.49,0.29 [0.16 – 0.49],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,BLR,Belarus,Year,2020,true,,,,,,,,,,,,,0.29,,,0.2,,0.42,0.29 [0.2 – 0.42],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,ALB,Albania,Year,2020,true,,,,,,,,,,,,,0.29,,,0.23,,0.37,0.29 [0.23 – 0.37],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,ROU,Romania,Year,2020,true,,,,,,,,,,,,,0.29,,,0.24,,0.34,0.29 [0.24 – 0.34],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,SVK,Slovakia,Year,2020,true,,,,,,,,,,,,,0.31,,,0.25,,0.36,0.31 [0.25 – 0.36],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,ITA,Italy,Year,2020,true,,,,,,,,,,,,,0.33,,,0.28,,0.39,0.33 [0.28 – 0.39],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,WSM,Samoa,Year,2020,true,,,,,,,,,,,,,0.34,,,0.22,,0.53,0.34 [0.22 – 0.53],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,LKA,Sri Lanka,Year,2020,true,,,,,,,,,,,,,0.34,,,0.24,,0.45,0.34 [0.24 – 0.45],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,CYP,Cyprus,Year,2020,true,,,,,,,,,,,,,0.34,,,0.26,,0.45,0.34 [0.26 – 0.45],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,CAN,Canada,Year,2020,true,,,,,,,,,,,,,0.34,,,0.29,,0.39,0.34 [0.29 – 0.39],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,MHL,Marshall Islands,Year,2020,true,,,,,,,,,,,,,0.35,,,0.28,,0.46,0.35 [0.28 – 0.46],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,NAM,Namibia,Year,2020,true,,,,,,,,,,,,,0.36,,,0.3,,0.43,0.36 [0.3 – 0.43],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,NIU,Niue,Year,2020,true,,,,,,,,,,,,,0.37,,,0.3,,0.47,0.37 [0.3 – 0.47],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,PHL,Philippines,Year,2020,true,,,,,,,,,,,,,0.38,,,0.32,,0.43,0.38 [0.32 – 0.43],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,AFG,Afghanistan,Year,2020,true,,,,,,,,,,,,,0.39,,,0.29,,0.52,0.39 [0.29 – 0.52],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,GUY,Guyana,Year,2020,true,,,,,,,,,,,,,0.4,,,0.07,,2.11,0.4 [0.07 – 2.11],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,FSM,Micronesia (Federated States of),Year,2020,true,,,,,,,,,,,,,0.4,,,0.3,,0.53,0.4 [0.3 – 0.53],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,KEN,Kenya,Year,2020,true,,,,,,,,,,,,,0.4,,,0.33,,0.48,0.4 [0.33 – 0.48],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,MUS,Mauritius,Year,2020,true,,,,,,,,,,,,,0.41,,,0.06,,2.93,0.41 [0.06 – 2.93],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,GBR,United Kingdom of Great Britain and Northern Ireland,Year,2020,true,,,,,,,,,,,,,0.41,,,0.36,,0.47,0.41 [0.36 – 0.47],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,PRY,Paraguay,Year,2020,true,,,,,,,,,,,,,0.42,,,0.09,,2.08,0.42 [0.09 – 2.08],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,LBY,Libya,Year,2020,true,,,,,,,,,,,,,0.43,,,0.37,,0.51,0.43 [0.37 – 0.51],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,MNG,Mongolia,Year,2020,true,,,,,,,,,,,,,0.47,,,0.37,,0.59,0.47 [0.37 – 0.59],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,RWA,Rwanda,Year,2020,true,,,,,,,,,,,,,0.49,,,0.41,,0.6,0.49 [0.41 – 0.6],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,BGD,Bangladesh,Year,2020,true,,,,,,,,,,,,,0.51,,,0.43,,0.61,0.51 [0.43 – 0.61],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,NRU,Nauru,Year,2020,true,,,,,,,,,,,,,0.52,,,0.42,,0.66,0.52 [0.42 – 0.66],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,JAM,Jamaica,Year,2020,true,,,,,,,,,,,,,0.55,,,0.37,,0.79,0.55 [0.37 – 0.79],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,RUS,Russian Federation,Year,2020,true,,,,,,,,,,,,,0.55,,,0.46,,0.65,0.55 [0.46 – 0.65],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,JOR,Jordan,Year,2020,true,,,,,,,,,,,,,0.56,,,0.38,,0.77,0.56 [0.38 – 0.77],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,MOZ,Mozambique,Year,2020,true,,,,,,,,,,,,,0.59,,,0.21,,1.36,0.59 [0.21 – 1.36],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,BLZ,Belize,Year,2020,true,,,,,,,,,,,,,0.6,,,0.46,,0.76,0.6 [0.46 – 0.76],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,BIH,Bosnia and Herzegovina,Year,2020,true,,,,,,,,,,,,,0.63,,,0.21,,1.92,0.63 [0.21 – 1.92],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,VNM,Viet Nam,Year,2020,true,,,,,,,,,,,,,0.64,,,0.53,,0.76,0.64 [0.53 – 0.76],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,MNE,Montenegro,Year,2020,true,,,,,,,,,,,,,0.67,,,0.18,,2.17,0.67 [0.18 – 2.17],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,LAO,Lao People's Democratic Republic,Year,2020,true,,,,,,,,,,,,,0.68,,,0.58,,0.79,0.68 [0.58 – 0.79],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,DNK,Denmark,Year,2020,true,,,,,,,,,,,,,0.68,,,0.59,,0.79,0.68 [0.59 – 0.79],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,SYR,Syrian Arab Republic,Year,2020,true,,,,,,,,,,,,,0.69,,,0.4,,1.22,0.69 [0.4 – 1.22],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,TLS,Timor-Leste,Year,2020,true,,,,,,,,,,,,,0.72,,,0.55,,0.93,0.72 [0.55 – 0.93],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,NZL,New Zealand,Year,2020,true,,,,,,,,,,,,,0.77,,,0.64,,0.89,0.77 [0.64 – 0.89],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,FIN,Finland,Year,2020,true,,,,,,,,,,,,,0.81,,,0.23,,2.82,0.81 [0.23 – 2.82],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,SWZ,Eswatini,Year,2020,true,,,,,,,,,,,,,0.83,,,0.09,,6.87,0.83 [0.09 – 6.87],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,SLB,Solomon Islands,Year,2020,true,,,,,,,,,,,,,0.87,,,0.71,,1.05,0.87 [0.71 – 1.05],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,TON,Tonga,Year,2020,true,,,,,,,,,,,,,0.89,,,0.7,,1.13,0.89 [0.7 – 1.13],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,HUN,Hungary,Year,2020,true,,,,,,,,,,,,,0.9,,,0.6,,1.33,0.9 [0.6 – 1.33],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,PAK,Pakistan,Year,2020,true,,,,,,,,,,,,,0.91,,,0.79,,1.04,0.91 [0.79 – 1.04],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,SEN,Senegal,Year,2020,true,,,,,,,,,,,,,0.93,,,0.8,,1.08,0.93 [0.8 – 1.08],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,UGA,Uganda,Year,2020,true,,,,,,,,,,,,,0.96,,,0.81,,1.12,0.96 [0.81 – 1.12],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,JPN,Japan,Year,2020,true,,,,,,,,,,,,,0.96,,,0.85,,1.07,0.96 [0.85 – 1.07],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,TZA,United Republic of Tanzania,Year,2020,true,,,,,,,,,,,,,0.99,,,0.8,,1.21,0.99 [0.8 – 1.21],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,ERI,Eritrea,Year,2020,true,,,,,,,,,,,,,1.02,,,0.59,,1.71,1.02 [0.59 – 1.71],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AMR,Americas,Country,HTI,Haiti,Year,2020,true,,,,,,,,,,,,,1.04,,,0.75,,1.41,1.04 [0.75 – 1.41],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,MMR,Myanmar,Year,2020,true,,,,,,,,,,,,,1.11,,,0.91,,1.32,1.11 [0.91 – 1.32],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EUR,Europe,Country,SVN,Slovenia,Year,2020,true,,,,,,,,,,,,,1.12,,,0.27,,5.12,1.12 [0.27 – 5.12],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,COM,Comoros,Year,2020,true,,,,,,,,,,,,,1.16,,,0.15,,6.73,1.16 [0.15 – 6.73],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,LSO,Lesotho,Year,2020,true,,,,,,,,,,,,,1.22,,,0.14,,8.88,1.22 [0.14 – 8.88],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,SEAR,South-East Asia,Country,IDN,Indonesia,Year,2020,true,,,,,,,,,,,,,1.3,,,1.14,,1.49,1.3 [1.14 – 1.49],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,STP,Sao Tome and Principe,Year,2020,true,,,,,,,,,,,,,1.31,,,0.28,,6.38,1.31 [0.28 – 6.38],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,ZMB,Zambia,Year,2020,true,,,,,,,,,,,,,1.32,,,1.03,,1.64,1.32 [1.03 – 1.64],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,BDI,Burundi,Year,2020,true,,,,,,,,,,,,,1.35,,,0.81,,2.11,1.35 [0.81 – 2.11],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,PNG,Papua New Guinea,Year,2020,true,,,,,,,,,,,,,1.36,,,1.16,,1.59,1.36 [1.16 – 1.59],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,MWI,Malawi,Year,2020,true,,,,,,,,,,,,,1.39,,,1.08,,1.78,1.39 [1.08 – 1.78],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,KIR,Kiribati,Year,2020,true,,,,,,,,,,,,,1.57,,,1.27,,1.97,1.57 [1.27 – 1.97],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,ETH,Ethiopia,Year,2020,true,,,,,,,,,,,,,1.59,,,1.36,,1.85,1.59 [1.36 – 1.85],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,GMB,Gambia,Year,2020,true,,,,,,,,,,,,,1.6,,,1.35,,1.89,1.6 [1.35 – 1.89],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,SDN,Sudan,Year,2020,true,,,,,,,,,,,,,1.66,,,1.37,,2,1.66 [1.37 – 2],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,BFA,Burkina Faso,Year,2020,true,,,,,,,,,,,,,1.66,,,1.39,,1.93,1.66 [1.39 – 1.93],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,CMR,Cameroon,Year,2020,true,,,,,,,,,,,,,1.75,,,1.49,,2.05,1.75 [1.49 – 2.05],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,YEM,Yemen,Year,2020,true,,,,,,,,,,,,,1.76,,,1.47,,2.08,1.76 [1.47 – 2.08],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,SLE,Sierra Leone,Year,2020,true,,,,,,,,,,,,,1.98,,,1.66,,2.35,1.98 [1.66 – 2.35],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,TCD,Chad,Year,2020,true,,,,,,,,,,,,,10.79,,,9.15,,12.78,10.79 [9.15 – 12.78],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,SSD,South Sudan,Year,2020,true,,,,,,,,,,,,,13.03,,,11.29,,15.14,13.03 [11.29 – 15.14],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,GNB,Guinea-Bissau,Year,2020,true,,,,,,,,,,,,,2.11,,,0.41,,9.75,2.11 [0.41 – 9.75],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,GAB,Gabon,Year,2020,true,,,,,,,,,,,,,2.12,,,1.78,,2.48,2.12 [1.78 – 2.48],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,GHA,Ghana,Year,2020,true,,,,,,,,,,,,,2.13,,,1.75,,2.56,2.13 [1.75 – 2.56],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,MDG,Madagascar,Year,2020,true,,,,,,,,,,,,,2.13,,,1.79,,2.49,2.13 [1.79 – 2.49],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,WPR,Western Pacific,Country,VUT,Vanuatu,Year,2020,true,,,,,,,,,,,,,2.25,,,1.88,,2.68,2.25 [1.88 – 2.68],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,COG,Congo,Year,2020,true,,,,,,,,,,,,,2.56,,,1.94,,3.31,2.56 [1.94 – 3.31],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,ZWE,Zimbabwe,Year,2020,true,,,,,,,,,,,,,2.74,,,2.26,,3.27,2.74 [2.26 – 3.27],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,BEN,Benin,Year,2020,true,,,,,,,,,,,,,2.87,,,2.4,,3.44,2.87 [2.4 – 3.44],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,NGA,Nigeria,Year,2020,true,,,,,,,,,,,,,2.94,,,2.57,,3.32,2.94 [2.57 – 3.32],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,ZAF,South Africa,Year,2020,true,,,,,,,,,,,,,3.1,,,2.72,,3.5,3.1 [2.72 – 3.5],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,TGO,Togo,Year,2020,true,,,,,,,,,,,,,3.27,,,2.71,,3.92,3.27 [2.71 – 3.92],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,COD,Democratic Republic of the Congo,Year,2020,true,,,,,,,,,,,,,3.28,,,2.55,,4.2,3.28 [2.55 – 4.2],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,MRT,Mauritania,Year,2020,true,,,,,,,,,,,,,3.35,,,2.74,,4.13,3.35 [2.74 – 4.13],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,NER,Niger,Year,2020,true,,,,,,,,,,,,,3.44,,,2.63,,4.5,3.44 [2.63 – 4.5],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,CIV,Côte d’Ivoire,Year,2020,true,,,,,,,,,,,,,3.44,,,2.9,,4.06,3.44 [2.9 – 4.06],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,CAF,Central African Republic,Year,2020,true,,,,,,,,,,,,,3.75,,,3.21,,4.38,3.75 [3.21 – 4.38],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,AGO,Angola,Year,2020,true,,,,,,,,,,,,,4.57,,,3.64,,5.62,4.57 [3.64 – 5.62],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,MLI,Mali,Year,2020,true,,,,,,,,,,,,,4.62,,,3.78,,5.49,4.62 [3.78 – 5.49],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,LBR,Liberia,Year,2020,true,,,,,,,,,,,,,4.66,,,3.78,,5.69,4.66 [3.78 – 5.69],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,GNQ,Equatorial Guinea,Year,2020,true,,,,,,,,,,,,,6.07,,,5.06,,7.21,6.07 [5.06 – 7.21],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,AFR,Africa,Country,GIN,Guinea,Year,2020,true,,,,,,,,,,,,,6.07,,,5.1,,7.24,6.07 [5.1 – 7.24],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
SDGHEPHBSAGPRV,Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%),numeric,EMR,Eastern Mediterranean,Country,SOM,Somalia,Year,2020,true,,,,,,,,,,,,,6.32,,,5.51,,7.24,6.32 [5.51 – 7.24],,"Based on serosurveys at city, subnational or national level. World Health Organisation (WHO).",EN,2022-05-08T22:00:00.000Z
